on 21 Mar 2023
Last Applicant/ Owned by
320 Wakara Way
Salt Lake City
UT
84108
Serial Number
90979096 filed on 21st Apr 2021
Registration Number
7007667 registered on 21st Mar 2023
Correspondent Address
Katherine P. Califa
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"GENETICS"
"GENETICS" The mark consists of the word "MYRIAD" with the "M" appearing as a capital letter formed by four (4) lines that do not touch, and the remainder of the word appearing in lowercase letters, and the word "GENETICS" directly below "MYRIAD" appearing in lowercase letters. Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detectiRead More
Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; medical diagnostic reagents, assays, chemical preparations, and diagnostic test kits consisting primarily of reagents for medical diagnostic purposes, namely, testing of fluids; chemical reagents for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic test kits comprised of chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic kits consisting primarily of reagents for body fluid analysis and nucleic acid analysis and for detecting genetic conditions, disorders, and diseases for medical use
31st Jan 2022
31st Jan 2022
Medical test kits comprising specimen collection tubes and containers for collecting patient specimens, printed test forms, printed mailing materials, and printed user information inserts used in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; sample preparation device for medical diagnostic uses; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of tissue-based diagnostic testing, cytology and cell-based testing; blood, urine, and saliva medical specimen collection kits consisting of test tubes and self-mailer, used for health and genetic analysis and diagnostics
31st Jan 2022
31st Jan 2022
No 90979096
No Service/Collective Mark
No 131588-0101
No
No
No
No
No
No
No
No
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
The mark consists of the word "MYRIAD" with the "M" appearing as a capital letter formed by four (4) lines that do not touch, and the remainder of the word appearing in lowercase letters, and the word "GENETICS" directly below "MYRIAD" appearing in lowercase letters.
Status Date | Action Taken |
---|---|
21st Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
21st Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
14th Feb 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
13th Feb 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
04th Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
04th Feb 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
03rd Feb 2023 | STATEMENT OF USE PROCESSING COMPLETE |
03rd Feb 2023 | SOU EXTENSION 2 GRANTED |
03rd Feb 2023 | DIVISIONAL PROCESSING COMPLETE |
25th Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |